Stay updated on PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.

Latest updates to the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedTwo new fields appear: 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)'. The exact fields 'Results First Posted' and 'Last Update Posted' have been removed, indicating that those dates are estimates rather than fixed posting dates.SummaryDifference0.1%

- Check20 days agoChange DetectedResults have been posted, with submission and posting dates and an enrollment of 228. The page now includes details on SUDS and CGI-I outcomes for Visit 2 to Visit 3, and removes several prior measures such as the 0-100 self-report scale and investigator-impression items.SummaryDifference3%

- Check28 days agoChange DetectedA funding/operating-status notice about government shutdowns and NIH operations was removed from the page. This administrative change does not affect core trial content such as design, eligibility criteria, outcomes, or contact information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe screenshots show cosmetic UI/layout adjustments without changes to essential study details such as the trial status, enrollment, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference4%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.